Equity (Tables)

3 Months Ended

Oct. 02, 2021

Equity [Abstract]

Schedule of impact on results of operations of recording stock-based compensation by function

The impact on our results of operations of recording stock-based compensation by function for the periods presented was as follows (in millions):

	Three Months Ended
	October 2, 2021		September 26, 2020
Cost of sales	$	4.6	$	3.7
Research and development	5.0		4.4
Selling, general and administrative	15.2		11.4
Total stock-based compensation	$	24.8	$	19.5

Schedule of income tax benefit associated with stock-based compensation

Total income tax benefit associated with stock-based compensation recognized in our condensed consolidated statements of operations during the years presented was as follows (in millions):

	Three Months Ended
	October 2, 2021		September 26, 2020
Income tax benefit associated with stock-based compensation	$	4.0	$	5.3

Summary of awards activity

The following table summarizes our awards activity for the three months ended October 2, 2021 (in millions, except per share amounts):

	Restricted Stock Units			Performance Stock Units
	Number of Shares	Weighted-Average Grant Date Fair Value per Share		Number of Shares	Weighted-Average Grant Date Fair Value per Share
Balance as of July 3, 2021	1.8	$	76.02	0.3	$	75.68
Granted	1.0	86.71		0.2	85.90
Vested	(0.5)	76.58		(0.1)	78.26
Canceled	(0.1)	74.04		—	58.52
Balance as of October 2, 2021	2.2	$	80.84	0.4	$	80.16

Summary of awards available for grant

A summary of awards available for grant is as follows (in millions):

	Awards Available for Grant
Balance as of July 3, 2021	2.3
Granted	(1.2)
Canceled	0.1
Balance as of October 2, 2021	1.2